Cause of death, by non-communicable diseases, ages 5-14, female in Cuba
Cuba: Cause of death, by non-communicable diseases, ages 5-14, female was 67.7% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, female in Cuba, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths ages 5-14.
Analysis
Cuba recorded 67.7% for cause of death, by non-communicable diseases, ages 5-14, female in 2021.
The figure is down 12.6% on the previous year and up 3.7% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, female in Cuba peaked at 77.4% in 2020 and was at its lowest, 51.4%, in 2000.
That places Cuba 17th out of 184 countries with data for 2021, putting it in the top 10%.
Cause of death, by non-communicable diseases, ages 5-14, female in Cuba, year by year
| Year | % of total female deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 51.4% | — |
| 2010 | 65.3% | +27.0% |
| 2015 | 71.2% | +9.0% |
| 2019 | 68.1% | -4.2% |
| 2020 | 77.4% | +13.6% |
| 2021 | 67.7% | -12.6% |
Cuba compared with similar countries
- Cuba's 67.7% is above the median for upper middle income countries, which is 39.9%, 1.7× the median. (55 countries reporting)
- Cuba's 67.7% is above the median for Latin America & Caribbean, which is 44.5%, 1.5× the median. (32 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 51.4% | 51.4% | 51.4% | 1 |
| 2010s | 68.2% | 65.3% | 71.2% | 3 |
| 2020s | 72.6% | 67.7% | 77.4% | 2 |
Countries ranked near Cuba
More health data for Cuba
- Un projection of annual infant deaths, annual growth rate -1.47 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2059 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,696 deaths per 1,000 people (2090)
- Number of infants who die before age 1 67 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.62 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2020)
- Population ages 00-04, female, per capita 0.021 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.64 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2020)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, female in Cuba?
- Cause of death, by non-communicable diseases, ages 5-14, female in Cuba was 67.7% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, female recorded in Cuba?
- The highest recorded value was 77.4% in 2020.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, female recorded in Cuba?
- The lowest recorded value was 51.4% in 2000.
- How does Cuba rank for cause of death, by non-communicable diseases, ages 5-14, female?
- Cuba ranks 17th out of 184 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, female rising or falling in Cuba?
- Over the last ten years it is up 3.7%. The long-run trend across the full record is rising.
- Where does this Cuba data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.